Results 191 to 200 of about 9,605 (202)

Considerations of critical quality attributes in the analytical comparability assessment of biosimilar products

Biologicals, 2017
Chan-Wha Kim
exaly  

The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion

Journal of Oncology Pharmacy Practice, 2019
Martin Schiestl
exaly  

A randomized study comparing the pharmacokinetics of the potential biosimilar PF-06438179/GP1111 with Remicade® (infliximab) in healthy subjects (REFLECTIONS B537-01)

Expert Review of Clinical Immunology, 2018
Chandrasekhar Udata, Donghua Yin
exaly  

Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease

Therapeutic Advances in Gastroenterology, 2018
Mohammad Kadivar, L Angelison, Olof Grip   +2 more
exaly  

The Future of Biosimilar Insulins

Diabetes Spectrum, 2016
Ross J Bindler
exaly  

Biosimilars

International Journal of Pharmaceutical Medicine, 2007
Martin K Kuhlmann, David Goldsmith, Adrian Covic   +2 more
openaire   +1 more source

Biosimilars: How Similar are They?

The International Journal of Artificial Organs, 2005
openaire   +3 more sources

Biosimilarity

2018
openaire   +2 more sources

Bracing for the biosimilar wave

Nature Reviews Drug Discovery, 2017
exaly  

Biosimilar liquid-metal living matter

Matter
Xi Zhao
exaly